MHP
CASM

Manatuck Hill Partners’s CAS Medical Systems, Inc. CASM Stock Holding History

Manatuck Hill Partners’s Portfolio CASM Stock Details CASM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50,000
Closed -$46K – 99
2017
Q3 		$46K Buy
+50,000
New +$51.2K 0.02% 80

Other funds holding CASM

ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
TCM
TD Capital Management Memphis, Tennessee $1.11B AUM 10.06% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Manatuck Hill Partners's CASM Position: Q4 2017 in Review

Manatuck Hill Partners sold out of CAS Medical Systems, Inc. (CASM) in Q4 2017, closing a stake of 50,000 shares — an estimated $46K sold.

Manatuck Hill Partners first reported a position in CASM in Q3 2017 and held it in 1 quarter. The position peaked at $46K in Q3 2017. 19 funds tracked by Wall St. Rank hold CASM as of Q4 2017.

  • Manatuck Hill Partners reported no remaining CAS Medical Systems, Inc. position as of Q4 2017 after selling out during the quarter.
  • Manatuck Hill Partners sold 50,000 CAS Medical Systems, Inc. shares in Q4 2017, an estimated $46K.
  • Manatuck Hill Partners first reported a position in CAS Medical Systems, Inc. in Q3 2017 and held it in 1 quarter.
  • Manatuck Hill Partners's CAS Medical Systems, Inc. position peaked at $46K in Q3 2017.
  • 19 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q4 2017.

Based on Manatuck Hill Partners's 13F filing for Q4 2017, filed 14 Feb 2018.